Glyceryl_guaiacolate_ether
Category
Glyceryl_guaiacolate_ether Brand names, Glyceryl_guaiacolate_ether Analogs
Glyceryl_guaiacolate_ether Brand Names Mixture
No information avaliable
Glyceryl_guaiacolate_ether Chemical_Formula
C10H14O4
Glyceryl_guaiacolate_ether RX_link
http://www.rxlist.com/cgi/generic2/guaifen.htm
Glyceryl_guaiacolate_ether fda sheet
Glyceryl_guaiacolate_ether msds (material safety sheet)
Glyceryl_guaiacolate_ether Synthesis Reference
No information avaliable
Glyceryl_guaiacolate_ether Molecular Weight
198.216 g/mol
Glyceryl_guaiacolate_ether Melting Point
78.5 oC
Glyceryl_guaiacolate_ether H2O Solubility
50 mg/mL
Glyceryl_guaiacolate_ether State
Solid
Glyceryl_guaiacolate_ether LogP
0.95
Glyceryl_guaiacolate_ether Dosage Forms
Liquid; Powder for solution; Syrup; Tablet
Glyceryl_guaiacolate_ether Indication
Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections.
Glyceryl_guaiacolate_ether Pharmacology
Guaifenesin is an expectorant which increases the output of phlegm (sputum) and bronchial secretions by reducing adhesiveness and surface tension. The increased flow of less viscous secretions promotes ciliary action and changes a dry, unproductive cough to one that is more productive and less frequent. By reducing the viscosity and adhesiveness of secretions, guaifenesin increases the efficacy of the mucociliary mechanism in removing accumulated secretions from the upper and lower airway.
Glyceryl_guaiacolate_ether Absorption
Rapidly absorbed from the GI tract
Glyceryl_guaiacolate_ether Toxicity
LD50 1510 mg/kg (rat, oral)
Glyceryl_guaiacolate_ether Patient Information
No information avaliable
Glyceryl_guaiacolate_ether Organisms Affected
Humans and other mammals
